Clinical trials for breast cancer

78 currently recruiting clinical trials
Breast cancer

Phase 3 Breast cancer
#NCT04961996
HER2 Negative HR Positive Localized
Clinique de l'Europe d'Amiens (Amiens), Hôpital Saint Louis AP-HP (Paris)
Hoffmann-La Roche
Phase 3 Breast cancer
#NCT06195709
HER2 Negative HR Positive Metastatic 1 Targeted therapy Hormone therapy
Chemotherapy Car-T Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
Centre Léon Bérard (Lyon), Institut du cancer de Montpellier (Montpellier), Institut Curie (Saint Cloud) - Hôpital René Huguenin (Saint-Cloud), Institut Paoli-Calmettes (Marseille), Centre Eugene Marquis (Rennes) (and 1 more...)
Institut Curie
Phase 3 Breast cancer
#NCT06611891
HER2 Negative HR Positive Metastatic 1
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Phase 3 Breast cancer
#NCT04158362
HER2 Negative HR Positive Metastatic Systemic Treatment-Naive
Chemotherapy Hormone therapy
Hôpital privé Paul D'Egine - Ramsay Santé (Champigny-sur-Marne)
UNICANCER
Phase 3 Breast cancer
#NCT05232916
HER2 Positive Localized Locally Advanced Other mutation None Targeted therapy Targeted therapy
Systemic Treatment-Naive Systemic Treatment-Naive
Hôpital NOVO (Site de Pontoise) (Pontoise), Centre François Baclesse (Caen ), Hôpital Privé Drome Ardèche - Clinique Générale - Ramsay Santé (Valence), Institut Godinot (Reims), CHP Brest - Pasteur Vivalto Santé (Brest) (and 10 more...)
Greenwich LifeSciences, Inc.
Phase 3 Breast cancer
#NCT06393374
HER2 Negative HR Negative Localized Locally Advanced None Surgery Immunotherapy Chemotherapy Surgery Immunotherapy Chemotherapy
BRCA 1/2 Systemic Treatment-Naive Antibody Drug Conjugates (ADC) Systemic Treatment-Naive Antibody Drug Conjugates (ADC)
Centre Hospitalier Universitaire de Besançon (Besançon), Hôpital Franco Britannique (Levallois-Perret), Centre Jean Perrin (Clermont Ferrand ), Centre Henri Becquerel (Rouen ), Centre Hospitalier de la Côte Basque (Bayonne) (and 13 more...)
Merck Sharp & Dohme LLC
Phase 3 Breast cancer
#NCT06112379
HER2 Negative HR Negative Locally Advanced None Systemic Treatment-Naive
Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Radiotherapy Hormone therapy
Centre Hospitalier d'Avignon (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Institut du cancer de Montpellier (Montpellier), CHU Caen Normandie (Caen), CHU Reims (Reims) (and 6 more...)
AstraZeneca
Phase 3 Breast cancer
#NCT06018337
HER2 Low HR Positive Locally Advanced Metastatic 1 2 Targeted therapy Hormone therapy
Chemotherapy Antibody Drug Conjugates (ADC)
Hôpital Henri-Mondor AP-HP (Créteil), Institut de cancérologie du Gard (Nîmes), Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite), Centre Hospitalier Universitaire de Montpellier - Site de Saint Eloi (Montpellier), Centre Hospitalier Universitaire Angers (Angers ) (and 12 more...)
DualityBio Inc.
Phase 3 Breast cancer
#NCT05952557
HER2 Negative HR Positive Localized None Surgery Chemotherapy Radiotherapy Hormone therapy
Systemic Treatment-Naive
IUCT Oncopôle (Toulouse), Institut de Cancérologie de Lorraine - Alexis Vautrin (Vandœuvre-lès-Nancy), CGFL Dijon - Centre Régional De Lutte Contre Le Cancer Georges - François Leclerc (Dijon ), Centre Jean Perrin (Clermont Ferrand ), Institut de Cancérologie de l'Ouest - Site d'Angers (Angers ) (and 16 more...)
AstraZeneca
Phase 3 Breast cancer
#NCT05894239
HER2 Positive Locally Advanced Metastatic PIK3CA None
Immunotherapy Chemotherapy Targeted therapy Car-T Bispecific T-cell engager antibodies Antibody Drug Conjugates (ADC)
Institut Sainte Catherine (Avignon), Centre Hospitalier de la Côte Basque (Bayonne), Polyclinique Bordeaux Nord Aquitaine (Bordeaux)
Hoffmann-La Roche